Another pioneering study demonstrated that inhibiting Gal-1 gene expression in tumor cells in vivo promotes tumor rejection and stimulates the generation of a tumor-specific T cell-mediated response in syngeneic mice [47]. The gene discussed is LGALS1; the disease is neoplasm.